Covid vaccines may come with a tantalizing benefit that has nothing to do with the virus they’re designed to protect against: ...

A drug that harnesses the immune system to attack cancer cells has proved successful in preventing a rare and aggressive form ...

Scientists discover that loss of MTAP gene disables immune defenses in tumors; DFMO drug could reactivate STING pathway.

Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice ...

An analysis of patient records suggests that mRNA covid-19 vaccines boost the immune response to cancerous tumours when given ...

An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...

A new cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) shows that a drug that utilizes the body's ...

HIV is infamous for its ability to hide in the human body for decades, typically requiring long-term treatment to prevent a ...

A groundbreaking study reveals that cancer patients who received a COVID-19 mRNA vaccine within 100 days of starting ...

"Our study provides the first solid evidence that immunotherapy with pembrolizumab postsurgery may help people with Merkel ...

Cylembio plus pembrolizumab achieved a clinically relevant 19.4 months median progression free survival (mPFS) compared to 11.0 months mPFS with pembrolizumab alone; study narrowly missed progression ...

In a report published by Xinhua News Agency, the finals of the China International College Students' Innovation Competition ...